From ibogaine to LSD, the benefits of psychedelics are not yet backed up by strong medical evidence
A trip down southPhotograph: Eyevine Jul 4th 2024|Mexico City
Olivia has suffered with depression and struggled to form romantic attachments ever since she was sexually assaulted. Counselling and medication scarcely helped. So in September 2023 she flew to Mexico and joined a retreat that uses 5-MeO-DMT, a psychedelic compound, as a therapeutic agent. She was “terrified”, but says the drug was “an opening” and that it let her body “feel what it needed to feel to start processing” her assault. She plans to return to Mexico for more psychedelic therapy this year.
Indigenous people across Latin America have long used naturally occurring psychedelics. As a result, they tend to be legal and easy to obtain in the region, not banned as they are in the United States. After Life magazine published an article in 1957 by Gordon Wasson, an amateur botanist, about his experience taking magic mushrooms in Mexico, hippies and rockstars flocked there. Now growing numbers of people like Olivia (not her real name) are coming to use psychedelics therapeutically rather than recreationally. Lysergic acid diethylamide (LSD) is the best known, but the category includes 5-MeO-DMT (which can be synthesised but is also found in a toad and plants), psilocybin (found in mushrooms), mescaline (cactus) and DMT (found in ayahuasca, a drink brewed from a South American vine). Already have an account? Log in
Unlock your free trial to continue
Explore all our independent journalism for free for one month. Cancel any time
Free trial
Or continue reading this article
Register now Explore more Mexico The Americas July 6th 2024 China’s presence in Latin America has expanded dramatically Paraguay and Taiwan strengthen their embrace, for now Mexico has become a testing ground for psychedelic therapies Reuse this content The Economist today Handpicked stories, in your inbox A daily newsletter with the best of our journalismYes, I agree to receive exclusive content, offers and updates to products and services from The Economist Group. I can change these preferences at any […]
Mexico has become a testing ground for psychedelic therapies
